Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 25, 2025, titled "Glenmark Pharmaceuticals Announces Launch of Nebzmart® GFB Smartules® and GlenmarkAirz® FB Smartules®, World s First Nebulized Triple Therapy for COPD".